tiprankstipranks
Advertisement
Advertisement
Fennec Showcases New PEDMARK Data at 2026 ASCO
PremiumCompany AnnouncementsFennec Showcases New PEDMARK Data at 2026 ASCO
2M ago
Buy Rating on PEDMARK Undervalues Global Expansion and Pipeline Upside, Supporting $13 Target Price
Premium
Ratings
Buy Rating on PEDMARK Undervalues Global Expansion and Pipeline Upside, Supporting $13 Target Price
2M ago
Fennec Backs New PEDMARK Study Expanding Cisplatin Ototoxicity Research to Adult Cancers
Premium
Company Announcements
Fennec Backs New PEDMARK Study Expanding Cisplatin Ototoxicity Research to Adult Cancers
2M ago
Fennec reports Q4 EPS (17c), consensus 4c
PremiumThe FlyFennec reports Q4 EPS (17c), consensus 4c
3M ago
Is FENC a Buy, Before Earnings?
Premium
Pre-Earnings
Is FENC a Buy, Before Earnings?
3M ago
Fennec to Report 2025 Results as Global Rollout of PEDMARK Advances
Premium
Company Announcements
Fennec to Report 2025 Results as Global Rollout of PEDMARK Advances
3M ago
Fennec announces clinical research collaboration with Tampa General Hospital
PremiumThe FlyFennec announces clinical research collaboration with Tampa General Hospital
3M ago
Fennec Showcases Real-World Data Backing PEDMARK Use in Adult Head and Neck Cancer
Premium
Company Announcements
Fennec Showcases Real-World Data Backing PEDMARK Use in Adult Head and Neck Cancer
4M ago
Fennec presents real world date on use of Pedmark
Premium
The Fly
Fennec presents real world date on use of Pedmark
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100